Loading...
Sionna Therapeutics, Inc.
SION•NASDAQ
HealthcareBiotechnology
$17.22
$1.19(7.42%)
Sionna Therapeutics, Inc. (SION) Company Profile & Overview
Explore Sionna Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Sionna Therapeutics, Inc. (SION) Company Profile & Overview
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
SectorHealthcare
IndustryBiotechnology
CEOMr. Michael Cloonan M.B.A.
Contact Information
21 Hickory Drive Suite 500, Waltham, MA, 02451
Company Facts
41 Employees
CountryUS
Actively Trading